Burning questions, answered.

We operate on a direct-pay membership model and don't bill insurance. Base prices and program inclusions are published, and medication, additional testing, supplies, or outside services may cost extra as described for each program. HSA and FSA cards are accepted for eligible expenses, and we can provide invoices and receipts for you to submit to your plan.

HRT/TRT membership starts at $219 per month and includes the visits, routine treatment monitoring, eligible medication, supplies, messaging, and discounts specified for the selected membership.

Weight-management membership is $109 per month plus medication and includes eight scheduled follow-ups per year, routine monitoring, and program support. ED membership is $29 per month plus medication. Exact inclusions, exclusions, and any additional charges are confirmed before enrollment.

Dr. Brown leads clinical care and treatment decisions at Ignite HRT. Clinic staff may assist with scheduling, intake, vitals, blood draws, records, and other non-prescribing tasks. Ask the clinic if continuity for a particular appointment is important to you.

New-patient HRT, TRT, and weight-management visits are scheduled for 60 minutes. The clinician reviews your intake, health history, symptoms, medicines, and goals and performs a focused examination when appropriate. Staff may take vitals and draw blood for tests selected for your evaluation. Follow-up and result review depend on the service and clinical plan.

Testing is selected for the service, your history, and the treatment being considered. The HRT/TRT evaluation may include blood counts, metabolic and thyroid testing, blood sugar, prostate screening when appropriate, and relevant hormone tests.

Men being evaluated for low testosterone generally need repeat fasting early-morning measurements. Routine hormone panels are usually not needed to identify perimenopause in patients 45 or older. Included and optional tests are confirmed before they are ordered.

Start with a free 15-minute informational phone consultation or book online. Listed starting prices are $395 for HRT/TRT new-patient visits, $215 for a weight-management new-patient visit, and $150 for the ED consultation; included services and any baseline tests are confirmed before ordering. The phone consultation does not include diagnosis or prescribing.

Prefer to talk it through? Call or text us at 503-925-6605.

Our Gresham clinic is at 1300 NE Linden Ave, Suite 5, east of Portland via I-84. Our Beaverton clinic is at 4540 SW Hall Blvd near Highway 217. Travel time varies substantially with your starting point, route, and traffic; check current directions before leaving. See locations & hours.

We care for both men and women. Menopausal hormone therapy may include estrogen and, for a patient with a uterus, a progestogen. Testosterone is not routine menopause replacement; it may be considered only for selected postmenopausal patients with diagnosed hypoactive sexual desire disorder after an appropriate assessment and counseling. Explore Women's HRT.

“Bioidentical” describes hormones that are chemically identical to hormones produced by the body. The term includes some FDA-approved estradiol and micronized progesterone products as well as custom-compounded preparations. It does not mean safer or more effective. FDA-approved products are generally preferred when an appropriate option is available; compounded products are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, quality, or dosing consistency before marketing.

Options may include FDA-approved oral or transdermal systemic estrogen, local vaginal estrogen, and progesterone or a progestin when indicated. The choice depends on symptoms, uterus status, medical history, risks, and preferences. Compounded products and pellets are not routinely recommended when an FDA-approved option can meet the patient's needs. Testosterone for women is off-label and should be limited to selected cases of diagnosed hypoactive sexual desire disorder with appropriate monitoring.

The new-patient visit is $395, covering the scheduled 60-minute appointment, a focused examination when appropriate, and the baseline lab work specified for the visit. HRT membership then starts at $219 per month for the services specified by the selected membership. Pricing is the same at both of our Portland-metro clinics, in Gresham and Beaverton.

Medication inclusions, monitoring, and any exclusions are confirmed before enrollment, and HSA and FSA cards are accepted for eligible expenses.

“Andropause” and “male menopause” are imprecise terms. Testosterone levels can shift as men age, but age on its own is not a diagnosis. Symptoms such as low sexual desire, erectile changes, fatigue, or loss of strength have many possible causes. Hypogonadism is diagnosed only when compatible symptoms or signs occur with consistently low testosterone on accurate testing, generally at least two fasting early-morning measurements, followed by evaluation for the cause.

Response and timing vary by symptom, formulation, underlying cause, and individual patient. Some changes may occur over weeks or months; other symptoms may not improve and may need a different evaluation. There is no guaranteed timetable. Treatment is monitored for response, adverse effects, and appropriate testosterone levels.

FDA-approved testosterone formulations include injections, gels, patches, pellets, and nasal products. No route is best for everyone. Choice should consider expected hormone levels, dosing burden, skin-transfer risk, adverse effects, cost, and patient preference. Doses are adjusted to an appropriate physiologic range and clinical response, not to pursue supraphysiologic “optimization.”

A single result—whether normal, borderline, or low—does not determine candidacy for testosterone therapy. Diagnosis generally requires compatible symptoms plus at least two low fasting early-morning total testosterone results. Free testosterone may add information when total testosterone is near the lower limit or sex hormone-binding globulin is altered. If testing does not confirm testosterone deficiency, other causes of the symptoms should be evaluated.

Testosterone therapy can suppress sperm production and is generally avoided when near-term fertility is desired. It can raise hematocrit and blood pressure and may cause acne, fluid retention, breast symptoms, or worsening sleep apnea. Certain prostate findings, elevated hematocrit, untreated severe sleep apnea, uncontrolled heart failure, recent heart attack or stroke, thrombophilia, and other conditions require avoidance, deferral, or specialist evaluation. Ongoing symptom, blood-count, testosterone, blood-pressure, and appropriate prostate monitoring is important.

The new-patient TRT evaluation is $395 and includes the scheduled 60-minute visit and the baseline laboratory work specified for it. If treatment is appropriate, TRT membership starts at $219 per month and covers the visits, routine monitoring, eligible medication, and supplies specified by the selected membership. Pricing is the same at both of our Portland-metro clinics, in Gresham and Beaverton.

We do not bill insurance; HSA and FSA cards are accepted for eligible expenses. Exact inclusions and any additional charges are confirmed before enrollment.

Online TRT services generally handle evaluation and follow-up remotely and send you to a third-party site for lab work. Ignite HRT is an in-person clinic: visits happen at our Gresham and Beaverton offices, blood draws are done at the clinic, a physical examination is performed when appropriate, and one clinician — Dr. Brown — is responsible for your evaluation, treatment decisions, and ongoing monitoring.

Remote follow-up may be available for some established patients; eligibility depends on the patient's location and the clinician's applicable licensure.

Prescription weight-management medication may be one part of chronic obesity care for eligible patients. It is used alongside nutrition, physical activity, behavioral support, and management of relevant health conditions. Medication choice depends on medical and family history, other medicines, pregnancy plans, risks, cost, and patient preference. See how our program works.

Options include medicines approved for long-term weight management, such as Wegovy (semaglutide) and Zepbound (tirzepatide), as well as other agents. Phentermine alone is FDA-approved only for short-term use. Compounded versions of semaglutide or tirzepatide are not FDA-approved and are not generic equivalents of approved branded products. The exact product, approval status, pharmacy, expected benefits, risks, duration, and cost should be clear before treatment.

Obesity is a chronic disease, and FDA-approved semaglutide and tirzepatide weight-management products are approved for long-term use. Treatment may continue long term or indefinitely while it remains effective, tolerated, accessible, and clinically appropriate. Duration is a shared decision based on benefits, adverse effects, health goals, access, and patient preference.

There is no universal monthly percentage. Results vary substantially by medication and product, dose, health status, side effects, adherence, and treatment duration. Your clinician should discuss evidence from the prescribing information for the specific product being considered and set an individualized health goal. No amount or timetable is guaranteed.

Many weight-management medicines are increased gradually to improve tolerability. Weight change is assessed over months rather than promised by a particular week. Response and side effects are reviewed throughout treatment, and the plan may change if a medicine is not effective or tolerated.

Prescription weight-management medication is used alongside nutrition, physical activity, behavioral support, and management of relevant health conditions. Recommendations are individualized to health status, ability, preferences, and treatment. Nutrition and activity guidance are included as described for the membership.

Reaching a goal weight does not automatically mean treatment should end. Some patients continue long-term treatment while it remains beneficial and tolerated; others choose or need to stop. Make that decision with the prescribing clinician. There is no universal requirement to taper a GLP-1 medicine—follow the plan for the specific product and patient.

Weight regain is common after weight-management medication is stopped. Nutrition, physical activity, behavioral support, and ongoing follow-up remain important, but they do not guarantee that weight will be maintained. If regain occurs, the clinician may discuss restarting treatment or another evidence-based option.

No. GLP-1 and GIP/GLP-1 medicines commonly cause gastrointestinal effects and have serious warnings and precautions that vary by product. These may include pancreatitis, gallbladder disease, kidney injury from dehydration, severe gastrointestinal reactions, hypoglycemia with certain diabetes medicines, and hypersensitivity reactions. Wegovy and Zepbound are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN2 and should not be used during pregnancy. The current prescribing information and your complete history must be reviewed before treatment.

Dr. Brown leads the clinical evaluation, while staff may assist with intake, testing, scheduling, and records. Health information is handled as described in our Privacy Policy and on our Health Information Privacy page, including uses or disclosures permitted or required by law. A free phone call is available for general questions, but it is not a diagnosis, prescription visit, or substitute for a clinical evaluation.

Not necessarily. Testosterone deficiency is one possible contributor, but ED alone does not establish it. Testing is selected based on your symptoms and history. A diagnosis generally requires compatible symptoms plus consistently low testosterone on two separate early-morning measurements — that comes before any discussion of testosterone therapy.

The initial ED consultation is $150 and includes two clinical visits: a 30-minute intake and focused exam, then a 30-minute findings and lab review, if applicable. If treatment is appropriate, ED membership is $29 per month plus medication, which is priced separately and varies depending on which medication fits your plan.

Extra visits, supplies, and add-on or specialty testing are separate unless expressly included in your care plan, and options and costs are reviewed before anything is prescribed. Explore ED treatment.